Results 81 to 90 of about 1,968 (182)

Phytochemical‐Based Strategies for Lung Cancer: Clinical Insights Into Pleiotropic Molecular Signaling and Therapeutic Roles

open access: yesPhytotherapy Research, Volume 40, Issue 4, Page 2003-2024, April 2026.
Lung cancer (LC) remains the leading cause of global cancer‐related death. Phytochemicals from medicinal plants are increasingly being considered as potential LC treatment agents due to their multi‐targeted action, safety, and accessibility. These have anticancer properties by regulating key molecular signaling pathways.
Md. Rezaul Islam   +14 more
wiley   +1 more source

Sebaceous carcinoma in situ as a concept and diagnostic entity

open access: yesDermatology Practical & Conceptual, 2017
Although carcinoma in situ has been accepted as a well-established concept and diagnostic category, for reasons unknown sebaceous carcinoma in situ has not been recognized yet in general pathology or dermatopathology.
Miglena K. Komforti   +2 more
doaj  

Electrochemotherapy with bleomycin of different types of cutaneous tumours in a ferret (Mustela putorius furo)

open access: yesRadiology and Oncology, 2017
Mast cell tumour, sebaceous gland adenoma, and less common squamous papilloma are skin tumours in ferrets (Mustela putorius furo), and early excisional surgery is usually the treatment of choice.
Racnik Jozko   +6 more
doaj   +1 more source

Giant pleomorphic adenoma of the parotid gland [PDF]

open access: yes, 2008
Pleomorphic adenoma is the most common type of all benign and malignant salivary gland tumors, involving more frequently the parotid gland. It is a benign tumor with a slow and continuous growth that without treatment can reach an enormous size.
Almeida, Oslei Paes de   +4 more
core  

Tetracycline Actions Relevant to Rosacea Treatment [PDF]

open access: yes, 2009
Until today, the pathogenesis of rosacea is not known in detail. Yet in recent years evidence has been accumulating that rosacea with its common symptoms such as inflammatory lesions, erythema, telangiectasia, phymatous changes, and ocular symptoms is of
Korting, Hans Christian, Schöllmann, C.
core   +1 more source

Robustness of a convolutional neural network trained on dermoscopic images and challenged with close‐up images

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 504-513, April 2026.
Summary Background and Objectives Deep learning‐convolutional neural networks (DL‐CNNs) have demonstrated high diagnostic accuracy within the domain of dermoscopy. However, many clinical settings lack dermoscopic devices, requiring reliance on close‐up images. This study evaluates the robustness of a DL‐CNN trained on dermoscopic images when challenged
Anastasia Sophie Vollmer   +6 more
wiley   +1 more source

The molecular cartography of malignant and benign sebaceous tumours

open access: yesNature Communications
Sebaceous tumours (STs) are rare skin appendage tumours and include benign sebaceous adenoma (SA) and sebaceoma (SM), malignant extra-ocular sebaceous carcinoma (SC-E) and peri-ocular sebaceous carcinoma (SC-O). Here, an extensive worldwide collection of
I. Ferreira   +26 more
doaj   +1 more source

Sebaceous Adenoma of Eyelid

open access: yes, 2023
Aims: To report a case of Sebaceous Adenoma of eyelid in 30 years old male and its diagnosis and management. Case Report: We described a case of 30yr old male patient presented to our hospital complaining of swelling over medial part of the left lower eyelid since 1year. Patient was suspected as left eye sebaceous cyst.
openaire   +1 more source

Synchronous sebaceous lymphadenoma with squamous cell carcinoma – case report

open access: yesWorld Journal of Surgical Oncology, 2003
Background Sebaceous lymphadenoma is a rare benign salivary gland tumour of uncertain histogenesis. So is synchronous occurrence of two benign or malignant neoplasms.
Panicker Sathibai, Shukla Mridula
doaj  

Exploring the interdependencies of research funders in the UK [PDF]

open access: yes, 2014
Investment in medical research is vital to the continuing improvement of the UK's health and wealth. It is through research that we expand our understanding of disease and develop new treatments for patients.
Crane, P   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy